Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia

por Vráblová, Lucia, Divoký, Vladimír, Kořalková, Pavla, Poláková, Kateřina Machová, Kriegová, Eva, Janská, Romana, Grohmann, Jan, Holzerová, Milena, Papajík, Tomáš, Faber, Edgar
Publicado 2023

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

por Srutova, Klara, Curik, Nikola, Burda, Pavel, Savvulidi, Filipp, Silvestri, Giovannino, Trotta, Rossana, Klamova, Hana, Pecherkova, Pavla, Sovova, Zofie, Koblihova, Jitka, Stopka, Tomas, Perrotti, Danilo, Polakova, Katerina Machova
Publicado 2018

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients

por Soverini, Simona, De Benedittis, Caterina, Polakova, Katerina Machova, Linhartova, Jana, Castagnetti, Fausto, Gugliotta, Gabriele, Papayannidis, Cristina, Mancini, Manuela, Klamova, Hana, Salvucci, Marzia, Crugnola, Monica, Iurlo, Alessandra, Albano, Francesco, Russo, Domenico, Rosti, Gianantonio, Cavo, Michele, Baccarani, Michele, Martinelli, Giovanni
Publicado 2016

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY

por Efficace, Fabio, Mahon, Francois-Xavier, Richter, Johan, Piciocchi, Alfonso, Cipriani, Marta, Nicolini, Franck Emmanuel, Hjorth-Hansen, Henrik, Almeida, Antonio, Janssen, Jeroen J. W. M., Mayer, Jiri, Koskenvesa, Perttu, Panayiotidis, Panayiotis, Olsson-Strömberg, Ulla, Martinez-Lopez, Joaquín, Rousselot, Philippe, Vestergaard, Hanne, Ehrencrona, Hans, Kairisto, Veli, Polakova, Katerina Machova, Mustjoki, Satu, Berger, Marc, Hochhaus, Andreas, Pfirrmann, Markus, Saussele, Susanne
Publicado 2023

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels

por Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová-Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel
Publicado 2013

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

por Salmon, Matthew, White, Helen E., Zizkova, Hana, Gottschalk, Andrea, Motlova, Eliska, Cerveira, Nuno, Colomer, Dolors, Coriu, Daniel, Franke, Georg N., Gottardi, Enrico, Izzo, Barbara, Jurcek, Tomas, Lion, Thomas, Schäfer, Vivien, Venturi, Claudia, Vigneri, Paolo, Zawada, Magdalena, Zuna, Jan, Hovorkova, Lenka, Koblihova, Jitka, Klamova, Hana, Markova, Marketa Stastna, Srbova, Dana, Benesova, Adela, Polivkova, Vaclava, Zackova, Daniela, Mayer, Jiri, Roeder, Ingo, Glauche, Ingmar, Ernst, Thomas, Hochhaus, Andreas, Polakova, Katerina Machova, Cross, Nicholas C. P.
Publicado 2022